What happened
Ampersend links the safety of AI-agent actions to wallet-level control, while the volume of such transactions lags behind interest in the topic.
Why it matters
Cost and error-action control is a basic prerequisite for using AI agents in financial operations, but the source does not yet show the scale of adoption.
Rodrigo Coelho, the CEO of Edge & Node and one of the founders of Ampersend, explained wallet-level control for managing multiple AI agents. He said such a layer can block an agent's overspending or an action based on a hallucination.
In the same Unchained piece, Coelho noted that banks, including BNY Mellon, are already testing agent trading. The actual volume of transactions, according to the source, has not yet matched the level of public interest in the topic. The data are presented in the metadata synopsis of the publication, so independent confirmation is limited.
Confirmed facts
- Rodrigo Coelho is the CEO of Edge & Node and one of the founders of Ampersend.
- Ampersend describes a wallet-level control layer that can block overspending by an AI agent or an action based on a hallucination.
- Banks, including BNY Mellon, are testing agent trading.
- The actual volume of transactions has not yet matched the level of interest in agent trading.
- Source — Unchained publication from 4 September 2026 year; available evidence is a synopsis of metadata.
Context
The material concerns infrastructure for managing the actions of multiple AI agents and agent trading.
What remains unknown
- How exactly is the wallet-level control layer implemented?
- Which banks, besides BNY Mellon, are participating in testing?
- What is the actual volume of agent trading transactions?
- Are there independent data on blocking overspending or erroneous actions by agents?
Editorial context
Confidence: medium
If the approach is practically applied, the next observable signals will be public data on real transactions and spending-limiting rules for agents. The main uncertainty is the lack of technical details, statistics, and independent verification of effectiveness in available material.